13D/13G Filings - Context Therapeutics Inc. (CNTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-01-09
5:05 pm
Sale
2023-01-09 13G Context Therapeutics Inc.
CNTX
HIRSCHMAN ORIN 0
0.000%
-1,285,771decrease
(Position Closed)
Filing
History
2022-10-27
1:22 pm
Purchase
2022-01-06 13G Context Therapeutics Inc.
CNTX
HIRSCHMAN ORIN 1,285,771
8.100%
1,285,771increase
(New Position)
Filing
History
2022-05-09
5:11 pm
Purchase
2022-04-28 13G Context Therapeutics Inc.
CNTX
Affinity Healthcare Fund, LP 883,654
5.530%
883,654increase
(New Position)
Filing
History
2022-02-02
4:54 pm
Purchase
2021-12-31 13G Context Therapeutics Inc.
CNTX
Hudson Bay Capital Management LP 1,000,000
8.360%
1,000,000increase
(New Position)
Filing
History
2022-01-04
9:13 pm
Purchase
2021-12-31 13G Context Therapeutics Inc.
CNTX
SABBY MANAGEMENT LLC 1,230,830
11.000%
230,830increase
(+23.08%)
Filing
History
2021-12-06
5:11 pm
Purchase
2021-12-02 13G Context Therapeutics Inc.
CNTX
SABBY MANAGEMENT LLC 1,000,000
11.000%
1,000,000increase
(New Position)
Filing
History
Goto Prev, 0, 1